Group One Trading, L.P. Fennec Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$5.71 - $8.54 $85,216 - $127,450	14,924 New	14,924 $121,000
Q4 2021 Feb 11, 2022	SELL	$3.89 - $10.01 $6,224 - $16,016	-1,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.51 - $9.62 $10,416 - $15,391	1,600 New	1,600 $15,000
Q1 2021 May 12, 2021	SELL	$6.21 - $8.68 $1,968 - $2,751	-317 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$5.99 - $8.55 $1,898 - $2,710	317 New	317 $2,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $156M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.